Immunotherapy in a Rabbit Model of Alzheimer’s Disease

Author： S. Woodruff-Pak Diana   Shriver Christina   Agelan Alexis   M. Manns Joanne   Coico Richard  

Publisher： Bentham Science Publishers

ISSN： 2210-3031

Source： Drug Delivery Letters, Vol.2, Iss.1, 2012-03, pp. : 14-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Transgenic animal model for Alzheimer’s disease

By  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 6, 1998-06 ,pp. : 729-732

Informa Healthcare

Access to resources Recommend Favorite

Alzheimer’s Disease

By  

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite

Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy

By  

Current Neuropharmacology, Vol. 11, Iss. 5, 2013-09 ,pp. : 491-498

Bentham Science Publishers

Access to resources Recommend Favorite

Subcellular Injuries in Alzheimer’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 4, 2014-06 ,pp. : 593-605

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s disease and related dementias:

By Williams M.   Davis R.E.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 6, 1997-06 ,pp. : 735-759

Informa Healthcare

Access to resources Recommend Favorite